These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Vitamin D supplementation after parathyroidectomy: effect on bone mineral density-a randomized double-blind study. Norenstedt S; Pernow Y; Zedenius J; Nordenström J; Sääf M; Granath F; Nilsson IL J Bone Miner Res; 2014 Apr; 29(4):960-7. PubMed ID: 24115138 [TBL] [Abstract][Full Text] [Related]
47. Parathyroidectomy Halts the Deterioration of Renal Function in Primary Hyperparathyroidism. Tassone F; Guarnieri A; Castellano E; Baffoni C; Attanasio R; Borretta G J Clin Endocrinol Metab; 2015 Aug; 100(8):3069-73. PubMed ID: 26079781 [TBL] [Abstract][Full Text] [Related]
48. Vitamin D status in primary hyperparathyroidism: a Southern European perspective. Tassone F; Gianotti L; Baffoni C; Visconti G; Pellegrino M; Cassibba S; Croce CG; Magro G; Cesario F; Attanasio R; Borretta G Clin Endocrinol (Oxf); 2013 Dec; 79(6):784-90. PubMed ID: 23521111 [TBL] [Abstract][Full Text] [Related]
49. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function. Moosgaard B; Vestergaard P; Heickendorff L; Mosekilde L Clin Endocrinol (Oxf); 2007 Jan; 66(1):35-42. PubMed ID: 17201799 [TBL] [Abstract][Full Text] [Related]
50. The evaluation of preoperative and postoperative fetuin-A levels in patients with primary hyperparathyroidism. Keskin M; Culha C; Gulcelik NE; Al LI; Senes M; Aral Y Niger J Clin Pract; 2019 Mar; 22(3):320-327. PubMed ID: 30837418 [TBL] [Abstract][Full Text] [Related]
51. Health-related quality of life after successful surgery for primary hyperparathyroidism: no additive effect from vitamin D supplementation: results of a double-blind randomized study. Åberg V; Norenstedt S; Zedenius J; Sääf M; Nordenström J; Pernow Y; Nilsson IL Eur J Endocrinol; 2015 Feb; 172(2):181-7. PubMed ID: 25414430 [TBL] [Abstract][Full Text] [Related]
52. Coexisting primary hyperparathyroidism and sarcoidosis cause increased angiotensin-converting enzyme and decreased parathyroid hormone and phosphate levels. Lim V; Clarke BL J Clin Endocrinol Metab; 2013 May; 98(5):1939-45. PubMed ID: 23493435 [TBL] [Abstract][Full Text] [Related]
53. The impact of baseline intact parathyroid hormone levels on severity of primary hyperparathyroidism and outcomes in patients undergoing surgery. Kandil E; Alabbas H; Tufaro AP; Carson KA; Tufano RP Arch Otolaryngol Head Neck Surg; 2010 Feb; 136(2):147-50. PubMed ID: 20157060 [TBL] [Abstract][Full Text] [Related]
54. Assessment of mean platelet volume (MPV) in primary hyperparathyroidism: effects of successful parathyroidectomy on MPV levels. Yilmaz H Endocr Regul; 2014 Oct; 48(4):182-8. PubMed ID: 25512191 [TBL] [Abstract][Full Text] [Related]
56. Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Moosgaard B; Christensen SE; Vestergaard P; Heickendorff L; Christiansen P; Mosekilde L Clin Endocrinol (Oxf); 2008 May; 68(5):707-15. PubMed ID: 17980013 [TBL] [Abstract][Full Text] [Related]
57. Vitamin D-binding protein levels in female patients with primary hyperparathyroidism. Wang X; Shapses SA; Wei S; Sukumar D; Ghosh J Endocr Pract; 2013; 19(4):609-13. PubMed ID: 23425651 [TBL] [Abstract][Full Text] [Related]
58. Effects of successful parathyroidectomy on metabolic cardiovascular risk factors in patients with severe primary hyperparathyroidism. Ishay A; Herer P; Luboshitzky R Endocr Pract; 2011; 17(4):584-90. PubMed ID: 21324826 [TBL] [Abstract][Full Text] [Related]
59. FREE AND BIOAVAILABLE 25-HYDROXYVITAMIN D LEVELS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM. Wang X; Shapses SA; Al-Hraishawi H Endocr Pract; 2017 Jan; 23(1):66-71. PubMed ID: 27682354 [TBL] [Abstract][Full Text] [Related]
60. Impact of vitamin D-related serum PTH reference values on the diagnosis of mild primary hyperparathyroidism, using bivariate calcium/PTH reference regions. Fillée C; Keller T; Mourad M; Brinkmann T; Ketelslegers JM Clin Endocrinol (Oxf); 2012 Jun; 76(6):785-9. PubMed ID: 22066864 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]